Finance

Lists
Why is GYRE down 28.94%?
Dive Deeper
GYRE:NASDAQ
Gyre Therapeutics Inc
$4.56
-28.94%
(-1.86) 1D
$4.60
+0.99% (+0.045)
After hours
Closed: Oct 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
$6.27
High
$6.30
Low
$4.52
Mkt. cap
482.98M
Avg. vol.
184.53K
Volume
394.08K
52-wk high
$9.14
52-wk low
$4.52
EPS
-$0.20
Beta
2.18
Shares outstanding
106.03M
No. of employees
625
Open
$6.27
High
$6.30
Low
$4.52
Mkt. cap
482.98M
Avg. vol.
184.53K
Volume
394.08K
52-wk high
$9.14
52-wk low
$4.52
EPS
-$0.20
Beta
2.18
Shares outstanding
106.03M
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
HeadquartersWinston-Salem, North Carolina, United States
SectorBiotechnology
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current $4.56
$20.00 (+339.08%)
Average
$19.00 (+317.12%)
Lowest
$18.00 (+295.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$18.00
+295.2%
10/05/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$20.00
+339.1%
08/10/2026
Roger Song
Jefferies
Buy
Initiated
$16.00
+251.3%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
30.56M
37.20M
24.43M
29.10M
Cost of goods sold
1.63M
1.74M
1.23M
2.21M
Cost of revenue
1.63M
1.74M
1.23M
2.21M
Research and development expenses
2.36M
4.82M
11.48M
19.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.65M
30.52M
24.31M
21.62M
Operating expense
22.01M
35.33M
35.79M
40.76M
Total operating expenses
23.64M
37.08M
37.02M
42.97M
Operating income
6.93M
120.00K
-12.59M
-13.86M
Other non operating income
604.00K
-2.31M
244.00K
-811.00K
EBT including unusual items
7.63M
-66.00K
-18.03M
-14.43M
EBT excluding unusual items
7.63M
-864.00K
-11.65M
-13.93M
Income tax expense
1.69M
1.30M
549.00K
-164.00K
Effective tax rate
22.19%
-1,969.70%
-3.04%
1.14%
Other operating expenses
-
-
-
-
Net income
3.61M
-1.72M
-10.30M
-10.60M
Net profit margin
11.81%
-4.63%
-42.16%
-36.44%
Earnings per share
0.03
0.05
-
-
Interest and investment income
100.00K
1.35M
743.00K
740.00K
Interest expense
-
-
-
-
Net interest expenses
100.00K
1.35M
743.00K
740.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
7.58M
815.00K
-11.92M
-12.38M
Gain or loss from assets sale
1.00K
2.00K
16.00K
2.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps